Ryan Specialty Group (RYAN) AI Stock Analysis

• Market Cap: $14.52B
• Dividend Yield: 0.84%
• Average Volume (3M): 1.92M
• Price to Earnings (P/E): 431.9
• Beta (1Y): 0.26
• Revenue Growth: 22.77%
• EPS Growth: -34.97%
• Country: US
• Employees: 5,556
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Specialty
• EPS (TTM): 0.47
• Shares Outstanding: 128,776,030
• 10 Day Avg. Volume: 1,746,546
• 30 Day Avg. Volume: 1,919,324
• PEG Ratio: 2.22
• Price to Book (P/B): 12.35
• Price to Sales (P/S): 3.08
• P/FCF Ratio: 16.56
• Enterprise Value/Market Cap: 1.56
• Enterprise Value/Revenue: 7.73
• Enterprise Value/Gross Profit: 18.82
• Enterprise Value/Ebitda: 26.64
• 1Y Price Target: $66.18
• Price Target Upside: 15.62% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 13
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 64 Neutral
• Price Target: $59.00 ▲(3.07% Upside)

Ryan Specialty Group's overall stock score is driven by strong financial performance and positive earnings call insights, highlighting robust revenue growth and strategic investments. However, high leverage, potential overvaluation, and bearish technical indicators weigh down the score.

Positive Factors

Revenue Growth

Strong revenue growth indicates effective market penetration and successful integration of acquisitions, supporting long-term expansion.

Strategic M&A Activity

Active M&A strategy enhances market position and diversifies revenue streams, contributing to sustainable growth.

Talent and Technology Investment

Investments in talent and technology foster innovation and operational efficiency, strengthening competitive advantage.

Negative Factors

Margin Pressure

Margin pressure from strategic investments may limit short-term profitability, though it could yield long-term benefits.

Property Pricing Headwinds

Property pricing challenges can impact revenue growth, necessitating strategic adjustments to maintain profitability.

Interest Expense Concerns

Flat interest expenses could strain profitability, affecting cash flow and limiting financial flexibility.

Ryan Specialty Group Business Overview & Revenue Model

Company Description

Ryan Specialty Group Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company was founded in 2010 and is headquartered in Chicago, Illinois.

How the Company Makes Money

Ryan Specialty Group generates revenue primarily through brokerage fees and commissions from the placement of insurance policies for clients. The company earns a significant portion of its income by acting as an intermediary between insurance carriers and clients, facilitating the underwriting process and providing access to specialty insurance products. Additionally, RYAN's managing general underwriting segment contributes to its revenue by generating profits from underwriting activities, including risk assessment and policy issuance. Strategic partnerships with various insurance carriers enhance RYAN's product offerings and market reach, further solidifying its revenue streams. The company's expertise in niche markets allows it to command competitive fees and maintain strong relationships with clients, thereby driving consistent earnings growth.

Ryan Specialty Group Financial Statement Overview

Summary

Ryan Specialty Group demonstrates strong revenue growth and efficient operations, as evidenced by high gross profit and EBITDA margins. However, the company faces challenges with high leverage and relatively low net profit margins. Cash flow generation is strong, but the conversion of income to cash could be improved. Overall, the financial health is stable with opportunities for enhancing profitability and reducing financial risk.

Income Statement

Ryan Specialty Group shows a solid revenue growth rate of 5.33% TTM, indicating a positive trajectory. The gross profit margin is strong at 71.29% TTM, reflecting efficient cost management. However, the net profit margin is relatively low at 3.40% TTM, suggesting room for improvement in profitability. EBIT and EBITDA margins are healthy, supporting operational efficiency.

Balance Sheet

The company has a high debt-to-equity ratio of 5.67 TTM, indicating significant leverage which could pose financial risks. Return on equity is moderate at 16.71% TTM, showing decent profitability relative to shareholder equity. The equity ratio is not explicitly provided, but the high leverage suggests a lower equity proportion in the capital structure.

Cash Flow

Free cash flow growth is robust at 12.09% TTM, indicating strong cash generation capabilities. The operating cash flow to net income ratio is low at 0.14 TTM, which may suggest potential issues in converting income into cash. However, the free cash flow to net income ratio is high at 0.89 TTM, reflecting good cash flow relative to earnings.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.94B	2.52B	2.08B	1.73B	1.43B	1.02B
Gross Profit	1.21B	924.63M	756.52M	596.21M	441.15M	360.06M
EBITDA	851.89M	598.63M	497.60M	418.32M	186.62M	235.58M
Net Income	69.17M	94.67M	61.04M	163.26M	65.87M	68.10M
Balance Sheet
Total Assets	9.85B	9.65B	7.25B	6.38B	5.46B	4.53B
Cash, Cash Equivalents and Short-Term Investments	153.49M	540.20M	838.79M	992.72M	386.96M	312.65M
Total Debt	3.58B	3.46B	2.16B	2.16B	1.68B	1.69B
Total Liabilities	8.62B	8.55B	6.27B	5.57B	4.86B	4.46B
Stockholders Equity	630.47M	627.66M	559.75M	478.40M	343.77M	69.79M
Cash Flow
Free Cash Flow	572.09M	467.87M	447.43M	320.47M	263.71M	122.89M
Operating Cash Flow	640.06M	514.87M	477.20M	335.51M	273.49M	135.39M
Investing Cash Flow	-1.18B	-1.76B	-476.23M	-22.42M	-457.94M	-865.42M
Financing Cash Flow	546.83M	1.17B	-12.61M	314.76M	429.28M	989.24M

Ryan Specialty Group Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 57.24
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RYAN, the sentiment is Neutral. The current price of 57.24 is above the 20-day moving average (MA) of 54.05, above the 50-day MA of 54.33, and below the 200-day MA of 63.50, indicating a neutral trend. The MACD of 0.72 indicates Negative momentum. The RSI at 58.39 is Neutral, neither overbought nor oversold. The STOCH value of 81.08 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for RYAN.

Ryan Specialty Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MTG	78 Outperform	$6.37B	9.15	14.40%	1.97%	2.20%	9.90%
FNF	74 Outperform	$15.86B	13.62	14.22%	3.51%	3.91%	55.78%
AIZ	73 Outperform	$11.32B	13.76	15.41%	1.41%	6.91%	17.60%
ESNT	73 Outperform	$6.10B	9.02	12.35%	1.99%	2.78%	-0.50%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
RYAN	64 Neutral	$14.52B	431.95	11.16%	0.84%	22.77%	-34.97%
FAF	60 Neutral	$6.51B	13.72	9.28%	3.47%	25.99%	426.44%

Ryan Specialty Group Corporate Events

Ryan Specialty Group’s Earnings Call: Growth Amid Challenges

Ryan Specialty Group Holdings, Inc. Class A recently held its earnings call, revealing a strong performance driven by significant revenue growth, successful mergers and acquisitions (M&A), and strategic investments in talent and technology. Despite these positive developments, the company faces challenges with margin pressures, property pricing headwinds, and interest expenses, leading to a balanced outlook.

Ryan Specialty Group Reports Strong Q3 2025 Results

Ryan Specialty Group Holdings, Inc. operates as a prominent international specialty insurance firm, providing innovative solutions in the insurance sector through its roles as a wholesale broker and managing underwriter. The company focuses on delivering specialty products and services to insurance brokers, agents, and carriers.

Ryan Specialty Group Reports Strong Q3 2025 Results

Ryan Specialty Holdings reported strong financial results for the third quarter ended September 30, 2025, with a 24.8% year-over-year increase in total revenue to $754.6 million. The company achieved significant growth in net income, adjusted EBITDAC, and adjusted diluted earnings per share, driven by organic growth and strategic investments in talent and technology, positioning itself as a leader in the specialty lines industry.

The most recent analyst rating on (RYAN) stock is a Buy with a $97.00 price target. To see the full list of analyst forecasts on Ryan Specialty Group stock, see the RYAN Stock Forecast page.

Ryan Specialty Group Appoints New Co-Presidents

On October 8, 2025, Ryan Specialty Holdings, Inc. announced the appointment of Stephen P. Keogh and Brendan M. Mulshine as Co-Presidents, succeeding Jeremiah Bickham who transitioned to a strategic advisor role. This leadership change is expected to leverage the extensive industry experience of both executives to drive the company’s continued growth and success, reflecting the firm’s commitment to sustainable and profitable expansion.

The most recent analyst rating on (RYAN) stock is a Buy with a $70.00 price target. To see the full list of analyst forecasts on Ryan Specialty Group stock, see the RYAN Stock Forecast page.

Ryan Specialty Group Appoints Michael Bungert to Board

On September 3, 2025, Ryan Specialty Holdings, Inc. appointed Michael G. Bungert, a veteran in the (re)insurance industry, to its Board of Directors and its Compensation and Governance Committee. Mr. Bungert, who has extensive experience in the insurance sector, is expected to bring strategic insights to the company. His appointment is seen as a move to strengthen Ryan Specialty’s position as a leader in the specialty insurance market, with Mr. Bungert’s experience anticipated to contribute to the firm’s innovative solutions and forward momentum.

The most recent analyst rating on (RYAN) stock is a Buy with a $68.00 price target. To see the full list of analyst forecasts on Ryan Specialty Group stock, see the RYAN Stock Forecast page.